Dova Pharma Hit With Investor Suit Over $915M Sobi Tie-Up
A Dova Pharmaceuticals Inc. investor filed a proposed class action Friday in Delaware federal court asserting the company has violated securities laws by not filing enough information about its proposed $915...To view the full article, register now.
Already a subscriber? Click here to view full article